| Literature DB >> 28728374 |
Hyun-Jun Jang1,2, Duk-Moon Kim3, Kyu-Bong Kim1, Jeong-Woong Park4, Jae-Young Choi4, Jin Hyeog Oh4, Ki-Duk Song2, Suhkmann Kim5, Byung-Wook Cho4.
Abstract
OBJECTIVE: Evaluation of exercise effects in racehorses is important in horseracing industry and animal health care. In this study, we compared metabolic patterns between before and after exercise to screen metabolic biomarkers for exercise effects in thoroughbreds.Entities:
Keywords: Exercise; Metabolic Analysis; Racehorse; Thoroughbred
Year: 2017 PMID: 28728374 PMCID: PMC5666199 DOI: 10.5713/ajas.17.0167
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Figure 1Metabolic clustering (left) and heatmap analysis of the differentially expressed metabolites (right) among the muscle, plasma, and urine.
Metabolic clustering among the muscle, plasma, and urine
| Clustering | Total | Metabolites |
|---|---|---|
| Muscle only | 11 | Anserine, aspartate, betaine, carnitine, cysteine, ethanol, fumarate, o-phosphocholine, o-phosphoethanolamine, serine, sn-glycero-3-phosphocholine |
| Plasma only | 3 | Formate, histidine, propionate |
| Urine only | 13 | Acetoacetate, allantoin, benzoate, citrate, citrulline, glutarate, hippurate, homocitrulline, inosine, methylsuccinate, phenylacetylglycine, trigonelline, trimethylamine n-oxide |
| Muscle and plasma | 5 | Choline, glycine, myo-inositol, phenylalanine, proline |
| Plasma and urine | 1 | Trimethylamine |
| Urine and muscle | 3 | Arginine, glucose, glycerol |
| Muscle, plasma, and urine | 16 | Lactate, creatine, taurine, glutamine, methionine, threonine, pyruvate, succinate, leucine, valine, isoleucine, glutamate, alanine, acetate, tyrosine, lysine |
Figure 2Analysis of the metabolic patterns in equine muscle, plasma, and urine before and after exercise. Orthogonal partial least square discriminant analysis (OPLS-DA) (R2X: 0.977; R2Y: 0.852; Q2: −0.142) (A) and variable importance plots (VIPs) for the muscle (D). OPLS-DA (R2X: 0.889; R2Y: 0.883; Q2: −1.33) (B) and VIPs for the plasma (E). OPLS-DA (R2X: 0.987; R2Y: 1; Q2: 0.971) (C) and VIPs for the urine (F).
VIP scores show the list of metabolites that contributed to the separation of the clustering in the muscle (R2X: 0.977; R2Y: 0.852; Q2: −0.142), plasma (R2X: 0.889; R2Y: 0.883; Q2: −1.33), and urine (R2X: 0.987; R2Y: 1; Q2: 0.971) before and after exercise
Figure 3On the basis of the differentially expressed (fold change >2 or <0.5) or high-variable importance plots (VIPs)-score (VIP >1) metabolites, concentration of the metabolites in the urine before and after exercise. Error bars are expressed as standard deviation; * p<0.05; ** p<0.01; *** p<0.001.
Figure 4The metabolic cycles for alanine, glutamine, lactate, and pyruvate from the muscle to the kidney, and the concentrations of alanine, glutamine, lactate, and pyruvate in the muscle, plasma, and urine before and after exercise.
List of metabolic pathways obtained using enrichment analysis for the differentially expressed (fold change >2 or <0.5) and high-VIP-score (VIP score >1) metabolites
| Related metabolic pathway | Total | Expected | Hits | Raw p | Holm p | FDR |
|---|---|---|---|---|---|---|
| Protein biosynthesis | 19 | 0.622 | 5 | 0.000217 | 0.0174 | 0.0113 |
| Urea cycle | 20 | 0.655 | 5 | 0.000283 | 0.0224 | 0.0113 |
| Glycine, serine and threonine metabolism | 26 | 0.851 | 5 | 0.00105 | 0.0817 | 0.0279 |
| Ammonia recycling | 18 | 0.589 | 4 | 0.00204 | 0.157 | 0.0408 |
| Arginine and proline metabolism | 26 | 0.851 | 4 | 0.00832 | 0.632 | 0.133 |
| Pyruvate metabolism | 20 | 0.655 | 3 | 0.0246 | 1 | 0.328 |
| Betaine metabolism | 10 | 0.327 | 2 | 0.0395 | 1 | 0.4 |
| Methionine metabolism | 24 | 0.785 | 3 | 0.04 | 1 | 0.4 |
| Aspartate metabolism | 12 | 0.393 | 2 | 0.0556 | 1 | 0.495 |
| Biotin metabolism | 4 | 0.131 | 1 | 0.125 | 1 | 0.999 |
| Alanine metabolism | 6 | 0.196 | 1 | 0.181 | 1 | 1 |
| Taurine and hypotaurine metabolism | 7 | 0.229 | 1 | 0.208 | 1 | 1 |
| Gluconeogenesis | 27 | 0.884 | 2 | 0.22 | 1 | 1 |
| Cysteine metabolism | 8 | 0.262 | 1 | 0.235 | 1 | 1 |
| Malate-aspartate shuttle | 8 | 0.262 | 1 | 0.235 | 1 | 1 |
| Butyrate metabolism | 9 | 0.295 | 1 | 0.26 | 1 | 1 |
| Glutathione metabolism | 10 | 0.327 | 1 | 0.284 | 1 | 1 |
| Ketone body metabolism | 10 | 0.327 | 1 | 0.284 | 1 | 1 |
| Glucose-alanine cycle | 12 | 0.393 | 1 | 0.331 | 1 | 1 |
| Beta-alanine metabolism | 13 | 0.425 | 1 | 0.353 | 1 | 1 |
| Phenylalanine and tyrosine metabolism | 13 | 0.425 | 1 | 0.353 | 1 | 1 |
| Lysine degradation | 13 | 0.425 | 1 | 0.353 | 1 | 1 |
| Glycerolipid metabolism | 13 | 0.425 | 1 | 0.353 | 1 | 1 |
| Purine metabolism | 45 | 1.47 | 2 | 0.44 | 1 | 1 |
| Propanoate metabolism | 18 | 0.589 | 1 | 0.454 | 1 | 1 |
| Glutamate metabolism | 18 | 0.589 | 1 | 0.454 | 1 | 1 |
| Phospholipid biosynthesis | 19 | 0.622 | 1 | 0.472 | 1 | 1 |
| Insulin signalling | 19 | 0.622 | 1 | 0.472 | 1 | 1 |
| Bile acid biosynthesis | 49 | 1.6 | 2 | 0.485 | 1 | 1 |
| Glycolysis | 21 | 0.687 | 1 | 0.507 | 1 | 1 |
| Porphyrin metabolism | 22 | 0.72 | 1 | 0.524 | 1 | 1 |
| Citric acid cycle | 23 | 0.753 | 1 | 0.54 | 1 | 1 |
| Galactose metabolism | 25 | 0.818 | 1 | 0.57 | 1 | 1 |
| Valine, leucine and isoleucine degradation | 36 | 1.18 | 1 | 0.706 | 1 | 1 |
| Pyrimidine metabolism | 36 | 1.18 | 1 | 0.706 | 1 | 1 |
| Tyrosine metabolism | 38 | 1.24 | 1 | 0.726 | 1 | 1 |
Raw p, raw p value; FDR, false discovery rate.